Carl June, the director of the Center for Cellular Immunotherapy in the Abramson Cancer Center and the director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, has been named a 2017 Fellow of the American Association for Cancer Research Academy. Dr. June was recognized for designing chimeric antigen receptor T cell immunotherapy for the treatment of refractory and relapsed chronic lymphocytic leukemia.

Fellows are chosen for work that has had a significant and enduring impact on the field. They are nominated and elected in a peer-review process.